The serum levels of the mitochondrial enzymes 1 ), aspartate transatninase II, malate dehydrogenase II and glutamate dehydrogenase were studied in 82 cases of acute hepatitis. The activity ratio alanine transaminase/glutamate dehydrogenase and the C/M-ratios of aspartate transaminase and malate dehydrogenase were also studied. The serum levels of the mitochondrial en2ymes glutamate dehydrogenase, aspartate transaminase Π and m'alate dehydrogenase II were "per se" useless in defining the severity of acute hepatitis. Conversely, the activity ratio alanine transaminase/glutamate dehydrogenase and the C/M-ratio 2 ) of aspartate transaminase proved to be very helpful for this purpose. These cytoplasmic/mitochondrial (C/M) ratios were very high in patients \vho later made a good recovery, while they were surprisingly low in those cases which progressed toward acute liver atrophy.
The estimation of the activity of transaminases and other enzymes in the serum, such as sorbitol dehydrogenase, malate dehydrogenase, guanine deaminase etc., is useless for determining the severity and prognosis of acute hepatitis: the prognosis may be good with either low or very high values of serum transaminases; while the same enzymes can fall to low levels in the presence of early liver atrophy. (For reviews on this subject see (1) (2) (3) (4) ). Working on the hypothesis that the level of mitochondrial enzymes in serum might correlate with the severity of liver damage in the course of acute hepatitis (5-8), we studied three such enzymes, glutamate dehydrogenase, mitochondrial aspartate aminotransferase, and malate dehydrogenase, in all patients who were admitted to our department with acute hepatitis in the last seven years. x ) Enzymes: Aspartate transaminase = L-Aspartate: 2-oxoglutarate aminotransferase (EC 2.6.1.1); Aspartate transaminase I = Cytosolic aspartate transaminase; Aspartate transaminase II = mitochondrial aspartate transaminase; Glutamate dehydrogenase = LGlutamate: NAD oxidoreductase (deaminating) (EC 1.4.1.2); Guanine deaminase = Guanine aminohydrolase (EC 3.5.4.3); Alanine transaminase = L-Alanine: 2-oxoglutarate aminotransferase (EC 2.6.1.2); Malate dehydrogenase = L-Malate: NAD oxidoreductase (EC 1.1.1.37); Malate dehydrogenase I = Cytosolic malate dehydrogenase; Malate dehydrogenase II = Mitochondrial malate dehydrogenase; Sorbitol dehydrogenase = L-Iditol: NAD oxidoreductase (EC 1.1.1.14).
2
) Abbreviation: C/M-ratio = Cytoplasmic/Mitochondrial ratio.
In addition, the activity ratio alanine transaminase/ glutamate dehydrogenase and the C/M-ratios of aspartate transaminase and malate dehydrogenase were also estimated in all patients. The activity ratio alamine transaminase/glutamate dehydrogenase is akeady known to be useful in the differential diagnosis of acute hepatitis and cholestatic jaundice (9-10).
Material and Methods
Anion-exchanger column chromatography was used to separate the mitochondrial isoenzymes of aspartate aminotransferase II and malate dehydrogenase Π. We employed columns (diameter 0.9 cm, length 15 cm) with a top feeding funnel, and the absorbent was DEAE Sephadex A 50 Medium. The ion-exchanger resin (activated according to the directions of the Pharmacia Co., Uppsala), was poured into the columns, at room temperature, until the final height of the settled suspension was 7-8 cm. It was then repeatedly washed with Na phosphate buffer, O.OOSwr, pH 7. The fresh sera, free from haemolysis, were dialysed for 4 hrs at 0-4° in a continuous-flow apparatus, against 25 1 of sodium phosphate buffer 0.008M, pH 7. After dialysis, 1 ml of serum was applied to the column at room temperature. After the sample had soaked into the column, elution was performed with 15 ml of sodium phosphate buffer Ο.ΟΟδκ, pH 7. The cytoplasmic isoenzymes of aspartate transaminase and malate dehydrogenase are adsorbed by anion-exchanger resins, such as DEAE Sephadex, while the mitochondrial components are not (11-13). Therefore, only aspartate transaminase Π and malate dehydrogenase II are contained in the eluate. The aspartate transaminase I and malate dehydrogenase I activities can either be calculated by subtraction of the mitochondria! activity from total aspartate transaminase and malate dehydrogenase activities of the Z, klin. Chem. u. klin. Biochem./ 10. Jahrg. 1972/Heft2 dialysed sample, or eluted with 15 ml of sodium phosphate buffer Λ 0.2M, pH 7 + NaCl 0.2M. The sensitivity, selectivity and reproducibility of this technique have been repeatedly tested; the results have been reported elsewhere (11). This method has proved suitable for experimental as well as clinical purposes (12-15). Aspartate transaminase and malate dehydrogenase activities were assayed in serum, before and after dialysis, and in the eluates. Aspartate transaminase activity was determined by KARMEN'S method, modified by BERGMEYER and BERNT (16); malate dehydrogenase by BERGMEYER'S method (17); alanine transaminase and glutamate dehydrogenase activities were determined in serum by BERGMEYER'S and SCHMIDT'S methods respectively (18, 19) .
Case material
The case material includes 82 patients with acute hepatitis; 70 of them made a good recovery, while 12 progressed toward acute liver atrophy. Data concerning the former group of patients consist of enzyme values found during the first week after the onset of jaundice; (patients who came under our observation after the first week of jaundice were not included in the case material). As far as the latter group is concerned, the data reported here concern blood samples taken before the onset of coma. Repeated assays of aspartate aminotransferase isoenzymes and glutamate dehydrogenase were made on some of these patients. The diagnosis of acute hepatitis was based upon cpidemiological, clinical, biochemical and histological criteria; the diagnosis of acute liver atrophy was based upon the clinical picture and, in most cases, on the histological features of liver biopsies obtained during necropsy.
Results and Discussion
The mean serum values i one standard error o£ aspartate transaminase II, malate dehydrogenase II and glutamate dehydrogenase in acute hepatitis and acute liver atrophy are summarized in table 1; the single enzyme values are reported in figure 1. Although some differences exist, the distribution of the enzyme values was surprisingly similar in the two groups of patients. The shaded areas of figure 1 malate dehydrogenase 6-38 U/l and for glutamate dehydrogenase 0.4-1.3 U/l, whereas the normal ranges of cytoplasmatic enzymes in serum are as follows: aspartate transaminase 4-15 U/l, malate dehydrogenase 34-75 U/l, alanine transaminase 3-18 U/l. Table 2 reports the mean values ± one standard error of the C/M-ratios of aspartate transaminase and malate dehydrogenase and the activity ratio alanine transaminase/glutamate dehydrogenase in patients with acute hepatitis and acute liver atrophy. The single values for these cytosolic/mitochondrial (C/M) ratios are reported in figure 2. The C/M-ratio of aspartate transaminase was high in patients who later made a good recovery (94.7% of values over 5), and low in those who progressed toward acute liver atrophy (82% of values under 5). The activity ratio alanine transaminase/glutamate dehydrogenase showed a similar behaviour (87.5% of Idoo, de Franchis, Bellobuono, Sfomni and Dioguardi: Serum Cytosolic/Mitochondrial Enzyme Ratio values over 16 in the former group of patients; 92% under 16 in the latter one). The C/M-ratio of malate dehydrogenase showed no differences in the two groups of patients. As far as the aspartate transaminase isoenzymes are concerned, our results are in agreement with that of VILLA and coworkers (20) , who observed a significant increase in the per cent aspartate transaminase II activity in the course of acute liver atrophy. We believe therefore that the estimation of the serum levels of mitochondrial enzymes alone is of little value in predicting the development of acute hepatitis: but the estimation of the C/M-ratio of aspartate transaminase and the activity ratio alanine transaminase/glutamate dehydrogenase can be very helpful for the early diagnosisof acute liver atrophy. This is very important to the physician who has to consider the more heroic forms of therapy for liver failure -such as steroids in high dosage, exchange transfusion, extracorporal liver perfusion or liver transplantation. Serum aspartate transaminase and malate dehydrogenase C/Mratios and alanine transaminase/glutamate dehydrogenase activity ratio in acute hepatitis and acute liver atrophy
